Lexaria Bioscience Corp., a global innovator in drug delivery platforms announced that dosing has been completed for human pilot study #3 investigating a DehydraTECH-processed version of the dual ...

Strata Decision Technology data finds the number of bariatric surgeries in the Chicago area may have fallen by more than half ...

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients reporting extreme side effects. | ITV National News ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.

2-Year U.S. Treasury Note Continuous Contract $102.754 0.063 0.06% 5-Year U.S. Treasury Note Continuous Contract $107.156 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.609 0.281 ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...